Sempio, C.; Campos-Palomino, J.; Klawitter, J.; Peters, E.N.; MacNair, L.; Haghdoost, M.; Bonn-Miller, M.O.; Harrison, A.; Babalonis, S.; Christians, U.;
et al. Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants. Pharmaceuticals 2024, 17, 1603.
https://doi.org/10.3390/ph17121603
AMA Style
Sempio C, Campos-Palomino J, Klawitter J, Peters EN, MacNair L, Haghdoost M, Bonn-Miller MO, Harrison A, Babalonis S, Christians U,
et al. Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants. Pharmaceuticals. 2024; 17(12):1603.
https://doi.org/10.3390/ph17121603
Chicago/Turabian Style
Sempio, Cristina, Jorge Campos-Palomino, Jelena Klawitter, Erica N. Peters, Laura MacNair, Mehdi Haghdoost, Marcel O. Bonn-Miller, Amy Harrison, Shanna Babalonis, Uwe Christians,
and et al. 2024. "Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants" Pharmaceuticals 17, no. 12: 1603.
https://doi.org/10.3390/ph17121603
APA Style
Sempio, C., Campos-Palomino, J., Klawitter, J., Peters, E. N., MacNair, L., Haghdoost, M., Bonn-Miller, M. O., Harrison, A., Babalonis, S., Christians, U., & Klawitter, J.
(2024). Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants. Pharmaceuticals, 17(12), 1603.
https://doi.org/10.3390/ph17121603
